| Patient | Phillis Wheatley |
|---|---|
| Date of birth | 1753-07-01 |
| Identifiers | MRN HR-EN015-SYN-TD; SSN (made up) 000-15-3360 |
| Document date | 1773-04-06 |
| Author | Abena Hartley-Okonkwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-week asthma review and planning for a long sea journey. [S]
Miss Wheatley returns six weeks after starting as-needed budesonide-formoterol. With the milder weather and the changes in the kitchen she is much better: she uses one inhalation two or three times a week, mostly before walking out in the wind, and has not woken at night for a month. Her two-week peak flow diary shows a best of 400 L/min. She has been invited abroad to see her book through the press and expects to sail in about a month, a long crossing followed by a summer in England, and she wants a plan in case her chest is bad at sea. She is prone to seasickness on short boat trips. [S]
| Element | Detail |
|---|---|
| Control | Asthma Control Test 21; reliever two or three times a week; no night waking for a month |
| Peak flow | Personal best 400 L/min |
| Upcoming | A long sea crossing in about a month and a summer abroad |
| System | Result | Finding |
|---|---|---|
| Respiratory | Negative | No night waking; slight wheeze in cold wind only |
| Ears, nose, mouth, and throat | Negative | No hoarseness or thrush |
| Gastrointestinal | Positive | Nausea on short boat trips in the past |
| Psychiatric | Negative | Looking forward to the journey, with some worry about falling ill far from help |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a day | One inhalation as needed | Respiratory tract route | 1773-02-23 to 1773-09-21 | completed | S |
| Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs | 40 mg each morning for five days if the action plan directs | Oral route | 1773-04-06 to 1773-10-26 | stopped | S |
| Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasickness | One tablet daily as needed at sea | Oral route | 1773-04-06 to 1773-09-21 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1773-04-06 | Body height | 152 | cm | S |
| 1773-04-06 | Body weight | 46.4 | kg | S |
| 1773-04-06 | Body mass index (BMI) [Ratio] | 20.1 | kg/m2 | S |
| 1773-04-06 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1773-04-06 | Diastolic blood pressure | 64 | mm[Hg] | S |
| 1773-04-06 | Heart rate | 76 | /min | S |
| 1773-04-06 | Respiratory rate | 14 | /min | S |
| 1773-04-06 | Body temperature | 36.6 | Cel | S |
| 1773-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1773-04-06 | Total score [ACT] | 21 | {score} | S | ||
| 1773-04-06 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 400 | L/min | 80 percent of her personal best of 400 L/min | Normal | S |
Vital signs recorded on 1773-04-06; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 46.4 kg; oxygen saturation 99 percent; peak flow 395 L/min in clinic |
| Respiratory | Clear on forced expiration |
| Inhaler technique | Correct with the spacer, checked by teach-back |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Wheeze, cough and breathlessness this winter, for about three months: symptoms on three or four days a week, waking with cough and a tight chest about twice a month, breathless climbing the hill streets in cold air; worse with cold wind, kitchen and fireplace smoke, and colds; called a weak chest and asthma since childhood but never tested or treated. Asthma to be confirmed with spirometry before and after bronchodilator and FeNO | resolved | confirmed | R06.2 | S — Synthetic presenting problem anchored to her documented frail, asthmatic childhood. Superseded by the diagnosis at the second visit. |
| Asthma, confirmed, mild persistent: variable airflow obstruction (FEV1/FVC 0.72, below the lower limit of normal, rising to 0.80 after bronchodilator; FEV1 2.24 L, 83 percent predicted, rising 330 mL or 15 percent); type 2 inflammation (FeNO 38 ppb, blood eosinophils 0.38 x10^3/uL, total IgE 165, house dust mite sensitization); tuberculosis infection test negative and chest X-ray clear. Triggers: cold air, kitchen and fireplace smoke, colds | active | confirmed | J45.30 | S — Synthetic modern confirmation linked to her documented frail, asthmatic childhood and her own later descriptions of asthma. |
| Prone to seasickness on boat trips; meclizine for the sea crossing; resolved on her return | active | confirmed | T75.3XXA | S — Synthetic travel-related problem. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Asthma Control Test, symptoms, night waking and reliever use | Every visit | Completed today | Asthma Control Test 21; reliever two or three times a week; no night waking |
| Imaging | Peak flow personal best | After starting treatment, to set action plan zones | Completed today | Best 400 L/min from the diary; 395 in clinic |
| Examination | Inhaler technique with her own inhaler, and adherence | Every visit; before any step-up | Completed today | Correct with the spacer |
| Self-management | Written asthma action plan | Every visit and after every exacerbation | Completed today | Zones set from her best; travel instructions added |
| Self-management | Exacerbation history (oral corticosteroid courses, emergency visits, admissions) | Every visit | Completed today | None |
| Self-management | Step-up or step-down assessment (GINA track 1) | Every visit | Completed today | Controlled at step 2; no change |
| Self-management | Triggers, exposures and smoking or vaping | Every visit | Completed today | Window and fan when cooking; avoids fireplace smoke; scarf in the wind |
| Self-management | Travel planning | Before any long journey away from care | Completed today | Medicine supply, standby course, updated plan, medical summary and seasickness treatment |
| Imaging | Repeat spirometry | Three to six months after starting treatment | Due | After her return in the autumn |
| Self-management | Private conversation: consent, safety and exploitation, and her own decisions | Every visit | Completed today | Seen alone; she will travel as a member of a party from the household, and she alone decides on her own care abroad |
Goal progress:
Guideline basis: CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); Motion Sickness (CDC Yellow Book: Health Information for International Travel) (2026)
Follow-up: Preventive visit before she sails. Asthma review on her return in the autumn, sooner by message if needed. Next scheduled visit 1773-04-27: periodic preventive visit before a long sea journey. [S]